(Q28323339)

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

30 October 2022

1 reference

S. Broder

1

1 reference

Europe PubMed Central

PubMed publication ID

1692446

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1692446

full work available at URL

30 October 2022

language of work or name

English

0 references

publication date

21 May 1990

0 references

https://api.elsevier.com/content/article/PII:0002934390904138?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

https://api.elsevier.com/content/article/PII:0002934390904138?httpAccept=text/plain

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

American Journal of Medicine

30 October 2022

published in

0 references

volume

88

0 references

issue

5B

0 references

page(s)

2S-7S

0 references

cites work

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.6189183

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction

30 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

30 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

30 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Infection of monocyte/macrophages by human T lymphotropic virus type III.

30 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

The role of mononuclear phagocytes in HTLV-III/LAV infection

30 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders

30 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.

30 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

HTLV-III in the Semen and Blood of a Healthy Homosexual Man

30 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members

30 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

30 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

30 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides

30 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

30 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine

30 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

30 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

30 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study

30 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report

30 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Effects of 2?,3?-dideoxynucleosides on mammalian cells and viruses

30 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.

30 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Strategies for antiviral therapy in AIDS.

30 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine.

30 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders.

30 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

30 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Dermatologic complications associated with administration of 2',3'-dideoxycytidine in patients with human immunodeficiency virus infection

30 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

Follow-up of neuropathy from 2',3'-dideoxycytidine

30 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(90)90413-8

30 October 2022

Identifiers